Condition
Fibroblast
Total Trials
5
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Not Yet Recruiting3
Unknown1
Recruiting1
Clinical Trials (5)
Showing 5 of 5 trials
NCT07855822Not Yet Recruiting
Effects of Standard PRP and Extracellular Vesicle-Enriched PRP on Human Gingival Fibroblasts
NCT07682636Recruiting
Keloid Pathogenesis And Fibroblast Activation Study
NCT07669636Not Yet Recruiting
Effects of Chlorhexidine on Human Gingival Fibroblasts
NCT06911476Not Yet Recruiting
From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19
NCT01154842UnknownPrimary
Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients
Showing all 5 trials